Suppr超能文献

圆锥角膜交联治疗后治疗结果的预测因素:一项验证性研究。

Predictors for treatment outcomes after corneal crosslinking for keratoconus: a validation study.

作者信息

Godefrooij Daniel A, Boom Kim, Soeters Nienke, Imhof Saskia M, Wisse Robert P L

机构信息

Utrecht Cornea Research Group, Department of Ophthalmology, University Medical Center Utrecht, Office E03.136, PO Box 85500, 3508 GA, Utrecht, The Netherlands.

出版信息

Int Ophthalmol. 2017 Apr;37(2):341-348. doi: 10.1007/s10792-016-0262-z. Epub 2016 May 24.

Abstract

Previous research suggested that baseline corrected distance visual acuity (CDVA) and maximum keratometry (Kmax) are the predictors for effectiveness of corneal crosslinking (CXL) for keratoconus. The aim of this study was to validate the previously determined predictors in a new treatment cohort. A prospective cohort of 112 eyes in 90 consecutive patients was used to validate the results of 102 eyes in 79 patients from our previous prospective cohort. All patients were treated using epithelium-off corneal CXL in a tertiary hospital setting. Primary outcomes were changes in CDVA (LogMAR) and Kmax between baseline and 1-year post-treatment. Predictive factors for both outcomes were determined using univariable and multivariable analyses. Lower pretreatment CDVA was found to be the sole independent factor predicting an improvement in CDVA 1 year after CXL (β coefficient: -0.476, P < 0.01). Kmax flattening is more likely to take place in eyes with preoperative central cones (β coefficient: 0.655, P < 0.01). These results are consistent with our initial research and indicate high reproducibility in the new cohort. The previously postulated prediction model for postoperative CDVA showed limited predictive value in the validation cohort (R  = 0.15). The clinical implication of these results is that patients with lower pretreatment visual acuity are more likely to benefit from CXL (with respect to visual acuity), and patients with more central cones will benefit more in terms of cone flattening. Furthermore, those results can be used to guide customization of the crosslinking treatment.

摘要

先前的研究表明,基线校正后的远视力(CDVA)和最大角膜曲率(Kmax)是圆锥角膜交联术(CXL)疗效的预测指标。本研究的目的是在一个新的治疗队列中验证先前确定的预测指标。对90例连续患者的112只眼进行前瞻性队列研究,以验证我们先前前瞻性队列中79例患者的102只眼的研究结果。所有患者均在三级医院环境中接受去上皮角膜交联术治疗。主要观察指标为基线和治疗后1年时CDVA(LogMAR)和Kmax的变化。使用单变量和多变量分析确定两个观察指标的预测因素。发现较低的治疗前CDVA是预测CXL术后1年CDVA改善的唯一独立因素(β系数:-0.476,P <0.01)。术前中央圆锥角膜的眼睛更有可能发生Kmax变平(β系数:0.655,P <0.01)。这些结果与我们最初的研究一致,表明在新队列中有很高的可重复性。先前假设的术后CDVA预测模型在验证队列中的预测价值有限(R = 0.15)。这些结果的临床意义在于,治疗前视力较低的患者更有可能从CXL(在视力方面)中获益,而中央圆锥角膜较多的患者在圆锥角膜变平方面将获益更多。此外,这些结果可用于指导交联治疗的定制。

相似文献

1
Predictors for treatment outcomes after corneal crosslinking for keratoconus: a validation study.
Int Ophthalmol. 2017 Apr;37(2):341-348. doi: 10.1007/s10792-016-0262-z. Epub 2016 May 24.
2
Prediction model for treatment outcomes 3 years after corneal cross-linking for keratoconus.
Int Ophthalmol. 2024 Sep 20;44(1):382. doi: 10.1007/s10792-024-03301-8.
4
A multivariate analysis and statistical model for predicting visual acuity and keratometry one year after cross-linking for keratoconus.
Am J Ophthalmol. 2014 Mar;157(3):519-25.e1-2. doi: 10.1016/j.ajo.2013.11.001. Epub 2013 Nov 6.
5
Transepithelial versus epithelium-off corneal cross-linking for the treatment of progressive keratoconus: a randomized controlled trial.
Am J Ophthalmol. 2015 May;159(5):821-8.e3. doi: 10.1016/j.ajo.2015.02.005. Epub 2015 Feb 19.
6
Prognostic factors for visual outcomes after crosslinking for keratoconus and post-LASIK ectasia.
Eur J Ophthalmol. 2013 Nov-Dec;23(6):799-806. doi: 10.5301/ejo.5000321. Epub 2013 Jun 9.
7
Corneal collagen cross-linking: a review of 1-year outcomes.
Eye Contact Lens. 2014 Nov;40(6):345-52. doi: 10.1097/ICL.0000000000000094.
8
Corneal Cross-linking to Halt the Progression of Keratoconus and Corneal Ectasia: Seven-Year Follow-up.
Am J Ophthalmol. 2015 Dec;160(6):1154-63. doi: 10.1016/j.ajo.2015.08.023. Epub 2015 Aug 22.
9
Refractive improvements and safety with topography-guided corneal crosslinking for keratoconus: 1-year results.
Br J Ophthalmol. 2017 Jul;101(7):920-925. doi: 10.1136/bjophthalmol-2016-309210. Epub 2016 Nov 29.

引用本文的文献

1
Digital transformation of care for keratoconus patients: ML modeling structural outcomes of corneal collagen cross-linking.
Front Med (Lausanne). 2025 Jun 4;12:1462653. doi: 10.3389/fmed.2025.1462653. eCollection 2025.
2
Prediction model for treatment outcomes 3 years after corneal cross-linking for keratoconus.
Int Ophthalmol. 2024 Sep 20;44(1):382. doi: 10.1007/s10792-024-03301-8.
4
Corneal collagen cross-linking in patients with keratoconus from the Dresden protocol to customized solutions: theoretical basis.
Int J Ophthalmol. 2024 May 18;17(5):951-962. doi: 10.18240/ijo.2024.05.21. eCollection 2024.
5
Epithelium-on versus epithelium-off corneal collagen crosslinking for keratoconus: a systematic review and meta-analysis.
Graefes Arch Clin Exp Ophthalmol. 2024 Jun;262(6):1683-1692. doi: 10.1007/s00417-023-06287-8. Epub 2023 Nov 8.
7
Outcome indicators for cross linking in pediatric keratoconus.
Front Med (Lausanne). 2023 May 12;10:1149641. doi: 10.3389/fmed.2023.1149641. eCollection 2023.
8
Outcomes of Corneal Topographical Kmax readings 3 months after Corneal Cross Linkage in Keratoconus patients.
J Community Hosp Intern Med Perspect. 2022 Sep 9;12(5):43-47. doi: 10.55729/2000-9666.1111. eCollection 2022.
10
Impact of keratoconus stage on outcome after corneal crosslinking.
BMC Ophthalmol. 2022 May 6;22(1):207. doi: 10.1186/s12886-022-02425-8.

本文引用的文献

1
Cone location-dependent outcomes after combined topography-guided photorefractive keratectomy and collagen cross-linking.
Am J Ophthalmol. 2015 Mar;159(3):419-25.e2. doi: 10.1016/j.ajo.2014.11.020. Epub 2014 Nov 18.
2
Genetics of keratoconus: where do we stand?
J Ophthalmol. 2014;2014:641708. doi: 10.1155/2014/641708. Epub 2014 Aug 28.
3
Corneal cross-linking for treatment of progressive keratoconus in various age groups.
J Refract Surg. 2014 Jul;30(7):454-60. doi: 10.3928/1081597X-20140527-03. Epub 2014 Jun 3.
4
A randomized, controlled trial of corneal collagen cross-linking in progressive keratoconus: three-year results.
Ophthalmology. 2014 Apr;121(4):812-21. doi: 10.1016/j.ophtha.2013.10.028. Epub 2014 Jan 6.
5
The pathogenesis of keratoconus.
Eye (Lond). 2014 Feb;28(2):189-95. doi: 10.1038/eye.2013.278. Epub 2013 Dec 20.
6
A multivariate analysis and statistical model for predicting visual acuity and keratometry one year after cross-linking for keratoconus.
Am J Ophthalmol. 2014 Mar;157(3):519-25.e1-2. doi: 10.1016/j.ajo.2013.11.001. Epub 2013 Nov 6.
7
Factors affecting outcomes of corneal collagen crosslinking treatment.
Eye (Lond). 2014 Jan;28(1):41-6. doi: 10.1038/eye.2013.224. Epub 2013 Oct 18.
8
[Keratoconus].
J Fr Ophtalmol. 2013 Sep;36(7):618-26. doi: 10.1016/j.jfo.2013.05.004. Epub 2013 Jul 30.
10
Effective corneal collagen crosslinking in advanced cases of progressive keratoconus.
J Cataract Refract Surg. 2013 Aug;39(8):1141-5. doi: 10.1016/j.jcrs.2013.01.045. Epub 2013 May 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验